Navigation Links
Phase II Trial of Experimental Anti-Coagulant Reports Safety and Outcomes Data
Date:11/11/2008

he regimen of patients who were already taking either aspirin or aspirin plus a thienopyridine. Regarding the safety endpoint, a composite of TIMI major bleeding, TIMI minor bleeding and any bleeding requiring medical attention, the researchers found that bleeding incidents increased with increasing doses of rivaroxaban. Bleeding ranged from 6.1 percent of patients receiving 5 milligrams (mg) of the drug each day to 15.3 percent of those receiving 20 mg daily compared to a 3.3 percent rate of bleeding incidents in patients receiving placebo, he said. Overall, 82 percent of all bleeding incidents fell in the mildest, non-TIMI tier of severity, he added.

The study reported no significant risk reduction (p=0.10) for rivaroxaban patients compared to placebo patients for the primary efficacy composite endpoint of all-cause death, heart attack, stroke and severe recurrent chest pain (ischemia) requiring revascularization with bypass surgery or angioplasty. It did report a significant risk reduction for treated vs. placebo patients for the secondary efficacy composite endpoint of death, heart attack or stroke and that finding did reach statistical significance (p=0.028), he said.

The study followed patients being treated for ACS who were first divided into two strata depending on what usual care they received at their home medical center, he explained. Patients receiving aspirin entered Stratum I (706 patients) while those receiving aspirin plus a thienopyridine entered Stratum II (2,731 patients). All patients then had either placebo or one of four total daily doses of the Factor Xa inhibitor on a once- or twice-a-day schedule added to their regimen.

Aspirin and thienopyridines are anti-clotting agents that interfere with platelet aggregation, which is the clumping together of these blood cells. Factor Xa inhibitors interfere with formation of the fine threads of thrombin that bind the platelets together into a blood clot, he said.

Warfarin, th
'/>"/>

SOURCE American Heart Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Repligen Initiates Phase 2b Clinical Trial of RG2417 in Bipolar Disorder
2. Ceregene Phase 2 Clinical Trial for Alzheimers Disease to be Funded by $5.4 Million Grant From National Institutes of Health
3. Derma Sciences Enrolls First Patient in DSC127 Phase II Study
4. Morria Biopharmaceuticals Plc Announces Preliminary Results Regarding Inflammatory Markers From its Phase II Study in Allergic Rhinitis
5. Phase 2a Data for MEDI-528 Presented at CHEST 2008
6. Anadys Pharmaceuticals Commences Dosing ANA598 in Hepatitis C Patients in Phase Ib Study
7. BioCryst Reports Positive Results From a Phase 2 Study of Intravenous Peramivir for Outpatient Influenza
8. QLT announces encouraging Phase II data from core study of Punctal Plug Drug Delivery System
9. Phase 3 Data Indicate Investigational 13-valent Vaccine May Broaden Protection Against Pneumoccocal Disease in Children Younger than Two
10. Teksouth Awarded $100,000 Defense Department Grant in First Phase of Medical Data Integration Project
11. Assessing the quality of phase I clinical trial abstracts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2015)... 18, 2015 More than 2000 styles ... at TheCelebrityDresses.com, the #1 online store carrying celebrity inspired ... girls have got their perfect dresses for their prom. ... fashion prom dresses at TheCelebrityDresses.com would be an ideal ... than 2000 prom dresses inspired by the most loved ...
(Date:4/18/2015)... Aureus Medical Group (web: aureusmedical.com), ... therapy jobs, has announced that it will participate ... Therapy Association Annual Conference to be held May ... SC. , The SCAPTA Annual Conference offers ... and services. , Representatives from Aureus Medical’s ...
(Date:4/18/2015)... 18, 2015 PHOENIX, ARIZONA – In ... with 11 other secure destruction professionals across the United ... (CSDS). He will now display “CSDS” as a professional ... before the National Association of Information Destruction 2015 Annual ... Grapevine, Texas. Of the 20 people who took the ...
(Date:4/17/2015)... (PRWEB) April 18, 2015 Heritage Woods ... begin its Supportive Living Week Celebration on April 20 ... having a healthy mind, body and soul. , The ... McLeansboro, Illinois, serves older adults of all incomes, including ... their independence. , Supportive Living Week is observed every ...
(Date:4/17/2015)... NY (PRWEB) April 18, 2015 Rosetta ... their facility, rounding out their list of diagnostic imaging ... center for patients on the Upper East Side of ... running at full capacity. The addition of PET-CT, combined ... their physicians the ability to work with patients through ...
Breaking Medicine News(10 mins):Health News:Prom Dresses 2015 on Sale at TheCelebrityDresses.com 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the South Carolina Physical Therapy Association Annual Conference 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 3
... By Amanda Gardner HealthDay Reporter , MONDAY, ... pediatricians is calling for a ban on all junk food ... means of slowing the rising tide of obesity among young ... issue of Pediatrics , the American Academy of Pediatrics ...
... This release is available in German . ... more than one million euros in research and development funding ... at the research neutron source FRM II. In a 2009 ... the high neutron flux the neutron source in Garching can ...
... Hughes Medical Institute, the Max Planck Society and the ... a new, top-tier, open access journal for biomedical and ... establish a new journal that will attract and define ... All research published in the journal will make highly ...
... HealthDay Reporter , SUNDAY, June 26 (HealthDay News) -- ... lose weight, and low-fat diets that are either high in ... researchers say. "I think there are two key messages ... a senior lecturer with the school of medicine and health ...
... illicit drug used by teenagers and adults around the world. ... States report smoking it, and most high schoolers say they ... smoking pot is no big deal. They cite reasons such ... it." Denise Walker, co-director of the University of Washington,s ...
... tested a predatory bacterium Bdellovibrio against ... found that it significantly reduced the numbers of Salmonella ... safe when ingested. The research was funded by ... Professor Liz Sockett,s team at The University of Nottingham, with ...
Cached Medicine News:Health News:Doctors Urge Ban on Junk Food Ads During Kids' Shows 2Health News:Doctors Urge Ban on Junk Food Ads During Kids' Shows 3Health News:Cancer diagnosis isotopes from Garching 2Health News:Leading research organizations announce top-tier journal for biomedical and life sciences 2Health News:Calories, Not Protein or Carbs, Are Key to Weight Loss: Study 2Health News:Calories, Not Protein or Carbs, Are Key to Weight Loss: Study 3Health News:2 talks with teens leads to less marijuana use for at least a year 2Health News:2 talks with teens leads to less marijuana use for at least a year 3Health News:Living antibiotic effective against Salmonella 2
(Date:4/17/2015)... , April 17, 2015 ... EGFR mutation   is a viable alternative to tumour biopsy ... testing in all patients with advanced NSCLC   ... effectiveness of plasma circulating tumour DNA (ctDNA) testing for epidermal ... with advanced non-small cell lung cancer (NSCLC) in clinical practice. ...
(Date:4/17/2015)... and Markets ( http://www.researchandmarkets.com/research/5hkm2f/medical_oxygen ) has announced ... Global Strategic Business Report" report to their offering. ... Medical Oxygen Systems in US$ Thousands by the following ... Regulators, and Oxygen Conserving Devices. The report provides separate ... , Japan , Europe ...
(Date:4/17/2015)... DUBLIN , Apr. 16, 2015 Research and ... addition of the "Corporate Reputation of Pharma in ... 2nd edition" report to their offering. ... perspectives from 130 patient groups with an interest in ... companies (and of the pharma industry as a whole) ...
Breaking Medicine Technology:"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 3"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 4Medical Oxygen Systems - 2015 Global Strategic Business Report Featuring Leading Players, Caire, Invacare & Philips Respironics 2Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 2Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 3Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 4Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 5
... NEW YORK, Nov. 3 Reportlinker.com announces ... available in its catalogue. , ... , http://www.reportlinker.com/p0157461/Contract-Pharmaceutical-Manufacturing-Research-and-Packaging.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire ... a thorough review of the global market ...
... Reportlinker.com announces that a new market research ... Chinese Markets for Bladder Cancer Treatment Drugs ... , China,s demand ... a fast pace in the past decade. In ...
Cached Medicine Technology:Reportlinker Adds Contract Pharmaceutical Manufacturing, Research and Packaging 2Reportlinker Adds Contract Pharmaceutical Manufacturing, Research and Packaging 3Reportlinker Adds Contract Pharmaceutical Manufacturing, Research and Packaging 4Reportlinker Adds Contract Pharmaceutical Manufacturing, Research and Packaging 5Reportlinker Adds Contract Pharmaceutical Manufacturing, Research and Packaging 6Reportlinker Adds Contract Pharmaceutical Manufacturing, Research and Packaging 7Reportlinker Adds Contract Pharmaceutical Manufacturing, Research and Packaging 8Reportlinker Adds Contract Pharmaceutical Manufacturing, Research and Packaging 9Reportlinker Adds Contract Pharmaceutical Manufacturing, Research and Packaging 10Reportlinker Adds Contract Pharmaceutical Manufacturing, Research and Packaging 11Reportlinker Adds Contract Pharmaceutical Manufacturing, Research and Packaging 12Reportlinker Adds Contract Pharmaceutical Manufacturing, Research and Packaging 13Reportlinker Adds Chinese Markets for Bladder Cancer Treatment Drugs 2Reportlinker Adds Chinese Markets for Bladder Cancer Treatment Drugs 3Reportlinker Adds Chinese Markets for Bladder Cancer Treatment Drugs 4Reportlinker Adds Chinese Markets for Bladder Cancer Treatment Drugs 5
... comfortable lightweight brace is designed for ... ulnar fractures. The anatomically correct design ... compression for optimal control of ulnar ... elbow motion is permitted to prevent ...
... Blue Line Wrist Control offers a custom ... support for Carpal Tunnel Syndrome, tendinitis, sprains, ... wrist. Careful design leaves fingers free for ... Lightweight metal stay can be contoured for ...
... The RCAI Dorsal Blocking Splint is constructed of ... The DBS protects the flexor tendons of the ... prevents scar tissue development in the later stages ... rest dorsally on the hand and positions the ...
Used for fractures of the phalanges where extension is required. Used to immobilize the joint following dislocation. Curved to conform to the finger.Choose from four sizes 1.5", 2.5", 4" and 6". Unpa...
Medicine Products: